Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Ordinary shares, nominal value $0.01 per share
-
Shares outstanding
-
3,394,124
-
Total 13F shares
-
261,518
-
Share change
-
+204,665
-
Total reported value
-
$1,340,824
-
Price per share
-
$5.13
-
Number of holders
-
32
-
Value change
-
+$1,050,293
-
Number of buys
-
12
-
Number of sells
-
8
Institutional Holders of EKSO BIONICS HOLDINGS, INC. - Ordinary shares, nominal value $0.01 per share (EKSO) as of Q3 2025
As of 30 Sep 2025,
EKSO BIONICS HOLDINGS, INC. - Ordinary shares, nominal value $0.01 per share (EKSO) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
261,518 shares.
The largest 10 holders included
Consolidated Portfolio Review Corp, CITADEL ADVISORS LLC, VANGUARD GROUP INC, UBS Group AG, DRW Securities, LLC, Cresset Asset Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, Shay Capital LLC, Virtu Financial LLC, and BlackRock, Inc..
This page lists
32
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.